Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Understanding lymphoid tissue immunology in human SLE and the impact of therapeutic interventions

Award Number: R01AI198773
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 06/02/2026
PERIOD OF PERFORMANCE END DATE: 05/31/2031

Group Awards By:

View Award Description

Understanding lymphoid tissue immunology in human SLE and the impact of therapeutic interventions - PROJECT SUMMARY Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by self-reactive antibodies (autoantibodies), and this chronic disease results in significant loss of quality of life and irreversible tissue damage that can result in organ failure and death. With SLE being a disease that affects many organs with a range of severity, newer targeted therapies are needed. Despite advances in understanding SLE, most human studies have relied on peripheral blood, limiting insights into the lymphoid tissue compartments which are likely to be the primary sites where autoreactive T and B cells are activate. As a result, major gaps remain in our understanding of tissue-specific immune mechanisms in SLE pathogenesis and treatment response. To address these knowledge gaps, we propose a novel approach using minimally invasive nasal swab lymphoid tissue sampling combined with high-dimensional immunologic analysis in SLE. Unlike blood-based testing, this method enables direct study of immune cells in a lymphoid tissue. Our team has developed and validated a safe and reproducible nasal swab protocol, paired with flow cytometry and transcriptomic profiling, to measure lymphoid tissue immune cell populations with high resolution. This method allows direct interrogation of immune responses in lymphoid tissue over time, which will be a key advance for SLE research. Importantly, such measurements can be done repeatedly, longitudinally over time, allowing for novel kinetic insights into SLE pathophysiology. This approach, combined with our human immunology expertise, can potentially provide unprecedented insights into SLE immune events. We will (1) characterize immune cell populations in lymphoid tissue from SLE patients vs. healthy controls; (2) identify features that correlate with disease activity over time; and (3) assess pre- and post-treatment immune dynamics in patients receiving common and new SLE therapies. Our central hypothesis is that longitudinal analysis of lymphoid tissue immune signatures will uncover critical drivers of SLE pathogenesis and treatment response. Additionally, we aim to identify key features of these T and B cells that could serve as targets for novel therapeutic interventions and/or biomarkers of disease activity and responses to treatment, thus potentially identify novel SLE therapeutic interventions and biomarkers. The project is entirely focused on human immunology in SLE patients, directly examining lymphoid tissue. Furthermore, we will, for the first time, collect detailed longitudinal data from lymphoid tissues from SLE patients, including patients receiving therapies. By advancing understanding of human adaptive immunity in lupus, this work could significantly improve patient stratification and treatment outcomes in SLE.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $929,095 )
2026	2026	LA JOLLA INSTITUTE FOR IMMUNOLOGY	9420 ATHENA CIR	LA JOLLA	CA	92037	SAN DIEGO	USA	Allergy and Infectious Diseases Research	000	1	6/3/2026	NEW	$929,095
														Subtotal = $929,095

Grand Total All Awards = $929,095

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Understanding lymphoid tissue immunology in human SLE and the impact of therapeutic interventions

Award Number: R01AI198773

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 06/02/2026

PERIOD OF PERFORMANCE END DATE: 05/31/2031

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer